Related Experiment Video
Updated: Dec 4, 2025
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.2K
Evolving trends in pancreatic cancer therapeutic development
Imani Bijou1,2, Jin Wang1,3
1Department of Pharmacology and Chemical Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA.
Annals of Pancreatic Cancer
|October 22, 2020
Summary
Pancreatic cancer survival remains poor despite advances. New targeted therapies, RNAi, and immunotherapies offer promise for improved treatment efficacy and patient outcomes.
Area of Science:
- Oncology
- Translational Research
- Cancer Therapeutics
Background:
- Pancreatic cancer presents a dismal 5-year survival rate, with incidence rising globally.
- Current treatments (surgery, chemotherapy) often lead to disease recurrence.
- There is a critical need for novel therapeutic agents and delivery systems to improve efficacy and reduce toxicity.
Purpose of the Study:
- To review current and emerging therapeutic strategies for pancreatic cancer.
- To highlight the importance of understanding tumor biology and biomarkers for precision medicine.
- To discuss the potential of new approaches to improve patient survival and quality of life.
Main Methods:
- Review of preclinical and clinical studies on novel pancreatic cancer therapies.
- Analysis of emerging therapeutic modalities including targeted therapies, RNA interference (RNAi), stromal targeting, and immunotherapies.
- Exploration of the role of biomarkers in guiding precision medicine approaches.
Main Results:
- Small molecule targeted therapies show promise in preclinical and clinical settings.
- RNAi, stromal therapies, and immunotherapies represent emerging avenues for treatment.
- Advancements in understanding pancreatic cancer biology are crucial for identifying therapeutic targets and biomarkers.
Conclusions:
- New therapeutic strategies, including targeted therapies and immunotherapies, offer hope for improved pancreatic cancer treatment.
- Precision medicine, guided by biomarkers and a deeper understanding of cancer biology, will be key to future advancements.
- Continued research is essential to overcome treatment resistance and enhance patient survival and quality of life.
Related Concept Videos
02:57Targeted Cancer Therapies
8.3K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.3K
02:50Combination Therapies and Personalized Medicine
5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
01:29Chronic Pancreatitis II: Collaborative Care
199
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
199
02:56Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
01:30Cancer Vaccines
801
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
801